Register Now
Youtube Linkedin Facebook
dxpx eu logo web

Our Investors

Partnering is the heart and soul of DxPx!

As last year, we expect to attract more than 150 investor companies to join our conference. Want to be among them?

aescuvest GmbH
aescuvest GmbH
Air Med
Am Hafen Capital
aMoon Fund
Angel santé
Angine Capital
Arch Venture Partners
Arkley Brinc VC
awesome capital Group
BayBG Bayerische Beteiligungsgesellschaft mbH
Beijing Clinical Service Center

Want to support us?

Our conference is bringing together innovation players with investors.
Send us a message
DxPx EU
BGI Group
BGI Genomics
Boehringer Ingelheim VC
Brandenburg Kapital GmbH
Brandenburg Kapital GmbH
btov partners
btov partners
Business Angels FRArhein Main
Button Capital
capricorn partners
Chemical Angel Network
Claret Capital Partners
convergence partners
Convergence Partners AG
Coparion GmbH & Co. KG
Coparion GmbH & Co. KG
Crowberry Capital
Crowberry Capital
Crowberry Capital
CS Ventures
Cytiva
Danaher
Danaher
Decheng Capital
Deutsche Bank
Deutsche Bank
Deutsche Boerse AG
Die Brueckenklopefe GmbH
Dynamk Capital
Earlybird VC Management GmbH & Co. KG
Earlybird VC Management GmbH & Co. KG
EIT Health e.V.
Elevation Investment
Fannin Innovation Studio
FLUXUNIT – OSRAM Ventures
First Momentum Ventures Management GmbH
GenScript
German Accelorator
Gilde Healthcare
GIMV
GreyBird Ventures LLC
Hightech-Gründerfonds GmbH
Hightech-Gründerfonds GmbH
IHM GBA
Hightech-Gründerfonds GmbH
i&i Prague s.r.o.
Illumina Ventures LLC
imec.xpand
Induran Ventures Inc
InHealth Ventures
InnovationIndustries
InnovationIndustries
InnovationIndustries
Invest Hong Kong Economic and Trade Office
Invest Hong Kong Economic and Trade Office
IPF Partners
IPF Partners
IQ Capital Partners LLP
JAFCO Asia
Korys Investments
Kurma Partners
Kurma Partners
Lion’s Head Global Partners LLP
Longliv Ventures
LSP Life Sciences Partners
M Ventures
McGovern Center
McGovern Center, Cornell University
Nasdaq Inc
Neckar Hub GmbH
NRW Bank
NRW Bank
NRW.Bank
Occident Group
Olympus America Inc
Pathena
Peppermint Venture Partners GmbH
Plug and Play
Portugal Ventures
000
Puhua Capital
PZhealth-Germany GmbH
Redalpine Venture Partners AG
000
Rox Health
Salus Partners SA
Sarstedt AG & Co. KG
SFW Capital Partners
Shanghai FOSUN Pharma Group Co. Ltd
Shanghai FOSUN Pharma Group Co. Ltd
SHS Gesellschaft für Beteiligungsmanagement mbH
STAR Capital Partnership LLP
Stetson Family Office
Summa Equity
SFW Capital Partners
Taikon Advisor Oy
TechVision Fonds
Thuja Capital Management BV
Tosoh USA Inc
Tyrolean Business Angel GmbH
Ventech SA
Verve Ventures
Vesalius Biocapital
Vigintillion Capital
Wellington Partners
000
000
Zukunftsfonds Heilbronn
Zukunftsfonds Heilbronn B2G

More investors will be uploaded soon!

Want to support us?

Our conference is bringing together innovation players with investors.
Send us a message
DxPx EU

Haven't ordered a ticket yet?

Be part of DxPx and discover the newest technology trends from the diagnostics, precision medicine and research tools industry.
Get your ticket
Tickets

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience